We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 187

Revised Hart-Scott-Rodino premerger notification thresholds for 2013

  • Greenberg Traurig LLP
  • -
  • USA
  • -
  • January 11 2013

On January 10, 2013, the Federal Trade Commission (FTC) announced revised Hart-Scott-Rodino Act (HSR) reporting thresholds under which transactions will

Damages actions before the UK courts - awaiting the next bus?

  • Greenberg Traurig LLP
  • -
  • United Kingdom
  • -
  • August 29 2012

London commuters have often ruefully commented that one can wait a long time for the morning bus to come only to find that when it arrives a second one is right behind it

Appeal concerning compatibility of penalties for doping offences with EU competition law

  • Greenberg Traurig LLP
  • -
  • European Union
  • -
  • April 13 2010

This GTM Alert discusses an appeal against a decision of the European Commission to reject a complaint by a former professional tennis player regarding the compatibility of penalties imposed for doping infringements with EU competition law

European Union’s Court of Justice rules against absolute ban on internet sales in Pierre Fabre selective distribution model

  • Greenberg Traurig LLP
  • -
  • European Union
  • -
  • October 19 2011

The Court of Justice of the European Union (CJEU) in its 13 October 2011 judgment has ruled that a restriction imposed on the online sale of cosmetics and personal care products breaches EU competition rules and cannot be justified in the terms of the block exemption for distribution and supply agreements

Price fixing in the booze market the government’s solution to binge drinking

  • Greenberg Traurig LLP
  • -
  • United Kingdom
  • -
  • December 14 2012

On 28 November 2012 the UK’s Home Office launched a consultation regarding proposals to deliver the Government’s policies aimed at cutting alcohol fuelled crime and anti-social behaviour

Assistant Attorney General Baer reports on recent developments in DOJ remedies and enforcement policies

  • Greenberg Traurig LLP
  • -
  • USA
  • -
  • November 18 2013

On September 25th, Bill Baer, Asst. Attorney General in charge of the Antitrust Division of the Department of Justice (DOJ), spoke at the Georgetown

FTC settles high-profile unfair competition case against Intel: agreement includes restrictions on various commercial practices

  • Greenberg Traurig LLP
  • -
  • USA
  • -
  • August 5 2010

On August 4, 2010, the Federal Trade Commission announced a proposed settlement (approved by a 4-0 vote, with Commissioner Kovacic recused, and subject to public comment) with Intel Corp. of charges of anticompetitive conduct in violation of Section 5 of the FTC Act

Second Circuit perforates Matsushita in reviving Publication Paper case

  • Greenberg Traurig LLP
  • -
  • USA
  • -
  • August 29 2012

Seizing upon the "opportunity to clarify the application of the standards established" more than a quarter-century ago in Matsushita Electric Industrial Co. v. Zenith Radio Corp. for determining the existence of a jury question as to collusive behavior, the Second Circuit reversed a summary judgment granted entered for an alleged price-fixer in In re Publication Paper Antitrust Litigation

The DOJ’s new merger remedies guideliness and the joint revised HSR rules

  • Greenberg Traurig LLP
  • -
  • USA
  • -
  • August 26 2011

The Antitrust Division of the U.S. Department of Justice (DOJ) has had a busy summer updating its merger policies

Second Circuit invites petition for in banc review in reverse payment case

  • Greenberg Traurig LLP
  • -
  • USA
  • -
  • June 10 2010

In a per curiam decision issued on April 29, 2010, a Second Circuit Court of Appeals panel ruled in Arkansas Carpenters Health & Welfare Fund v. Bayer AG (“Cipro”), that Bayer AG, the manufacturer of the branded antibiotic Cipro, and four drug manufacturers seeking regulatory approval to market a generic version of the drug did not violate Section 1 of the Sherman Act when they settled Bayer’s patent infringement suit, in part by agreeing to a so-called “reverse payment.”